Track topics on Twitter Track topics that are important to you
The presentation can be followed live, or afterwards on www.sobi.com. Slides used in the presentation will be made available on Sobi's website prior to Read more...
Swedish Orphan Biovitrum (Sobi) has started patient enrolment in the Phase III anaSTILLs clinical trial of Kineret (anakinra) for Still’s...Read More... The post Sobi enrols first patient in Phase I...
Fredrik Wetterlundh blir ny HR-chef på Sobi.
Swedish Orphan Biovitrum (Sobi) has received approval from Health Canada for an oral suspension formulation of Orfadin (nitisinone) to treat...Read More... The post Sobi receives approval for Orfadin ...
European regulators expanded treatment indications for Sobi's Kineret, or anakinra, to treat the rare auto-inflammatory disor -More-
European regulators have expanded the scope of Sobi’s Kineret to include the treatment of Still’s disease, a rare, systemic, multi-organ, auto-inflammatory disorder that affects around 25,...
The Republic of Ireland has become the first country in Europe to switch its entire population with haemophilia A and B treated with short-acting replacement clotting factors to Swedish Orphan Biovitr...
The US Food and Drug Administration (FDA) has accepted Swedish Orphan Biovitrum's (Sobi) new drug application and granted fast track status for mucopolysaccharidosis type IIIA (MPS IIIA) drug candidat...
Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. Sobi have a diversi...
Sobi is an international specialty healthcare company dedicated to rare diseases. Sobiâs mission is to develop and deliver innovative therapies and services to improve the li...
Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare ...
Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class re...
We have published hundreds of Sobi Inc. news stories on BioPortfolio along with dozens of Sobi Inc. Clinical Trials and PubMed Articles about Sobi Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sobi Inc. Companies in our database. You can also find out about relevant Sobi Inc. Drugs and Medications on this site too.